Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Maple Leaf Initiates a Medical Marijuana Growing Operation in U.S.A.

N.MGW

CALGARY, ALBERTA--(Marketwired - Sept. 11, 2014) - Maple Leaf Green World (TSX VENTURE:MGW) ("Maple Leaf" or the "Company") announces the Company has engaged Mr. Brian Patterson, Marc Montoya and Dillon Patterson to develop a medical Marijuana growing operation plan in California, U.S.A., as part of the Company's business strategy.

The medical marijuana business in California is estimated about $1 Billion a year according to L.A. Weekly magazine. With 23 States having already legalized marijuana for medical purpose, the potential market for medical marijuana in USA is tremendous and Maple Leaf's management feels this is the good time to enter the U.S. market.

Mr. Brian Patterson will be heading the team in developing a sound business plan for Maple Leaf. He holds a Bachelor degree in Finance from San Diego State University. He was involved in developing Real Estates before 2009 and since then he has been concentrated on developing and building coldframes ( greenhouse without heating system)for medical Marijuana in California. He is also the executive producer on a documentary about medicinal cannabis called " American Drug War 2 - Cannabis Destiny" in 2012 . He has spent over 100 hours interviewing cannabis doctors in U.S.A. in making the film and investigating the medicinal properties of the plant. He has also attended multiple conferences held throughout the US with doctors and nurses regarding the endocannabinoid system and he also has extensive knowledge of how the different THC and CBD cannabinoids in combination with their terpenes profiles affect the human body through the CB1 and CB2 receptor system in the human body.

Mr. Marc Montoya will be the Chief Grower for the U.S. growing operation. He is a Certified Honors Graduate from Oaksterdam University of California's Advanced Course Curriculum in Horticulture and Canabusiness in 2010. He has over 10 years of extensive Indoor/Outdoor greenhouse experience in growing Marijuana with high success rate in propagation management, advanced techniques practitioner in all aspects of Plant Husbandry and extensive knowledge of IPM solutions. He is also accredited with 3rd Place Hybrid Category (Platinum OG) 2012 High Times Cannabis Cup, Los Angeles.

Mr. Dillon Patterson will assist Mr. Montoya in managing the U.S. growing facility. He has attended the California State University at Fullerton for a degree in Bacholer of Art - Business Administration from 2006 to 2008. In 2008, he began a new career in Horticulture and Cannabis. He has extensive practical experience in managing greenhouse operation and in all aspects of cultivating and processing Marijuana.

Maple Leaf has also retained the services of a law firm in California that is well versed in the law and regulations regarding medical marijuana in that State. This law firm will assist the Company in applying all the necessary permits and licenses from the State of California and setting up a proper business structure in order to make this a legitimate and sustainable venture.

"While Health Canada still deliberates our MMPR application, this will be the good time to enter the much larger U.S. market. We are excited to have a team of expertise to join us, not only to spearhead the U.S. operation, but also to assist us to set up the shop when we get the MMPR license. " said Maple Leaf Green World President and CEO Raymond Lai. "This team's expertise and networking will help us to start up the U.S. operation in a very timely manner and ultimately generate revenue for the Company in the near future."

Corporate Update

MMPR Application - Since Maple Leaf's submission of an application on July 22, 2014, the Company has received a written confirmation and file number from Health Canada and has been addressing several queries and answering questions with Health Canada. The Company is happy with the progress and the timely responses from Health Canada.

Soil Enhancement Program in China - The contract with Lin Ze Bo Tech Co. Ltd (LZB)in Ordo, Inner Mongolia has expired and LZB has asked for an extension for 1 more year, as having determined the soil condition in Ordo is extremely poor. The Company has agreed to start another testing program for LZB in spring 2015.

Vegetable greenhouses construction with Taiping, Inner Mongolia - The contract has expired and the Company does not intend to extend, given that the medical marijuana projects in N. America demands significant attention from the management.

For further information regarding Maple Leaf Green World Inc., visit www.mlgreenworld.com.

About Maple Leaf Green World Inc.

Maple Leaf is a Canadian company that focuses in the agricultural/environmental industry with three main areas of activity:

  1. Eco-Agriculture - it pursues several projects around the world. In China, it is focused on growing value-added tree seedlings and nursery products that assist with anti-desertification.
  2. Renewable Energy - it pursues various renewable energy projects around the world, including Yellowhorn in China which would provide valuable Yellowhorn seeds and ultimately oil from such seeds for the manufacture of bio-diesel fuel and premium healthy cooking oil.
  3. Canadian MMPR - It pursues opportunities within the medical cannabis industry. Through an agreement with Woodmere Nursery Ltd., it's currently seeking a Canadian MMPR licensed producer status to grow medical cannabis in Canada for domestic consumption and export to approved countries.

Neither the TSX Venture Exchange or its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Certain statements in this news release including (i) statements that may contain words such as "anticipate", "could", "expect", "seek", "may" "intend", "will", "believe", "should", "project", "forecast", "plan" and similar expressions, including the negatives thereof, (ii) statements that are based on current expectations and estimates about the markets in which Maple Leaf operates and (iii) statements of belief, intentions and expectations about developments, results and events that will or may occur in the future, constitute "forward-looking statements" and are based on certain assumptions and analysis made by Maple Leaf. Forward-looking statements in this news release include, but are not limited to, statements with respect to future capital expenditures, including the amount, nature and timing thereof; other development trends within the agricultural industry, and status of, and ability to capitalize on, opportunities available to the Company and review business strategy; expansion and growth of Maple Leaf's business and operations and other such matters. Such forward-looking statements are subject to important risks and uncertainties, which are difficult to predict and that may affect Maple Leaf's operations, including, but are not limited to: the impact of general economic conditions; industry conditions; available equity or debt financing; government and regulatory developments including availability of requisite licences; product supply and demand; competition; and Maple Leaf's ability to attract and retain qualified personnel. Maple Leaf's actual results, performance or achievements could differ materially from those expressed in, or implied by, these forward-looking statements and, accordingly, no assurance can be given that any of the events anticipated by the forward-looking statements will transpire or occur, or if any of them do transpire or occur, what benefits Maple Leaf will derive there from.

Maple Leaf maintains a forward-looking statement database which is reviewed by management on a regular basis to ensure that no material change has occurred with respect to such forecasts. The Company will publicly disclose such material changes to its forward-looking statements as soon as they are known to management.

Maple Leaf Green World Inc.
Raymond Lai
Chairman, President & CEO
+1 (403) 452-4552 or +1 (403) 452-6900
rlai@mlreforestation.com
www.mlgreenworld.com



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today